RxNorm Semantic Concepts Index - 253
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "253".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2530 | Chymotrypsin A and B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2530 | Chymotrypsin A and B | Designated preferred name (PT) | YES | |
| RxCUI: 2530 | Chymotrypsin A and B | Full form of descriptor (FN) | YES | |
| RxCUI: 2530 | Chymotrypsin A and B | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2530 | Chymotrypsin A and B | Designated preferred name (PT) | YES | |
| RxCUI: 2530 | Chymotrypsin A and B | Full form of descriptor (FN) | YES | |
| RxCUI: 253000 | beta sitosterol 300 MG / zinc citrate 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253000 | beta sitosterol 300 MG / zinc citrate 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253010 | sodium nitrite 300 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253010 | sodium nitrite 300 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253010 | sodium nitrite 300 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253011 | folate 0.4 MG / vitamin B12 0.25 MG / vitamin B6 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253011 | folate 0.4 MG / vitamin B12 0.25 MG / vitamin B6 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253011 | folate 0.4 MG / vitamin B12 0.25 MG / vitamin B6 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530130 | .alpha.-cubebene, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2530131 | .alpha.-phellandrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2530132 | borneol, (+)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253014 | etanercept 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253014 | etanercept 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253015 | menthol 7 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253015 | menthol 7 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253016 | folate 0.2 MG/ML / Polysaccharide iron complex 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253016 | folate 0.2 MG/ML / Polysaccharide iron complex 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253020 | menthol 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253020 | menthol 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253020 | menthol 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253021 | glycerin 0.2 % / hypromellose 0.2 % / propylene glycol 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253021 | glycerin 0.2 % / hypromellose 0.2 % / propylene glycol 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253021 | glycerin 0.2 % / hypromellose 0.2 % / propylene glycol 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253029 | benzocaine 10 MG / menthol 4.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253029 | benzocaine 10 MG / menthol 4.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253038 | CHROMIUM PICOLINATE 0.2 MG/ML / vit-B3 20 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253038 | CHROMIUM PICOLINATE 0.2 MG/ML / vit-B3 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253038 | CHROMIUM PICOLINATE 0.2 MG/ML / vit-B3 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253038 | CHROMIUM PICOLINATE 0.2 MG/ML / vit-B3 20 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253039 | melatonin 1 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253039 | melatonin 1 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253039 | melatonin 1 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253041 | glucosamine hydrochloride 100 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530430 | Lymphocyte immunoglobulin | Designated preferred name (PT) | NO | |
| RxCUI: 2530430 | Lymphocyte immunoglobulin | Full form of descriptor (FN) | NO | |
| RxCUI: 2530430 | Lymphocyte immunoglobulin | Designated preferred name (PT) | NO | |
| RxCUI: 2530430 | Lymphocyte immunoglobulin | Full form of descriptor (FN) | NO | |
| RxCUI: 253046 | FESO4 50 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253046 | FESO4 50 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253056 | menthol 16 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253056 | menthol 16 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253056 | menthol 16 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253059 | levOCARNitine 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253059 | levOCARNitine 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253059 | levOCARNitine 500 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 253062 | magnesium aspartate 250 MG / potassium aspartate 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253062 | magnesium aspartate 250 MG / potassium aspartate 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253062 | magnesium aspartate 250 MG / potassium aspartate 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253062 | magnesium aspartate 250 MG / potassium aspartate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253063 | chondroitin sulfates 200 MG / glucosamine sulfate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253065 | benzocaine 10 MG / menthol 2.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253065 | benzocaine 10 MG / menthol 2.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253075 | carboxymethylcellulose 0.02 MG/MG / povidone 0.001 MG/MG Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530800 | hydrogen peroxide 26.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2530801 | hydrogen peroxide 2.65 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530801 | hydrogen peroxide 2.65 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530801 | hydrogen peroxide 2.65 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530802 | Preop | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2530803 | hydrogen peroxide 26.5 MG/ML [Preop] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2530804 | hydrogen peroxide Mouthwash [Preop] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2530805 | Preop Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2530806 | Preop Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2530807 | Preop Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2530808 | PreOp 2.65 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2530808 | PreOp 2.65 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530808 | PreOp 2.65 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530808 | PreOp 2.65 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253083 | vitamin B 12 1 MG / folic acid 0.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253083 | vitamin B 12 1 MG / folic acid 0.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253083 | vitamin B 12 1 MG / folic acid 0.8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253083 | vitamin B 12 1 MG / folic acid 0.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253084 | cyanocobalamin 1 MG / folic acid 0.8 MG / pyridoxine 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253084 | cyanocobalamin 1 MG / folic acid 0.8 MG / pyridoxine 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253084 | cyanocobalamin 1 MG / folic acid 0.8 MG / pyridoxine 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253084 | cyanocobalamin 1 MG / folic acid 0.8 MG / pyridoxine 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530881 | fosphenytoin sodium 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2530882 | fosphenytoin sodium 500 MG PE in 10 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530882 | fosphenytoin sodium 500 MG PE in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530883 | fosphenytoin sodium 50 MG/ML [Sesquient] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2530884 | Sesquient 500 MG PE in 10 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2530884 | Sesquient 500 MG PE in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530884 | Sesquient 500 MG PE in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530885 | fosphenytoin sodium 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2530886 | fosphenytoin sodium 50 MG/ML Injection [Sesquient] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2530886 | fosphenytoin sodium 50 MG/ML Injection [Sesquient] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530887 | dimethicone 0.018 MG/MG / zinc oxide 0.02 MG/MG [Dynashield] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2530888 | dimethicone / zinc oxide Topical Ointment [Dynashield] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2530889 | Dynashield (dimethicone 1.8 % / zinc oxide 2 % ) Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2530889 | Dynashield (dimethicone 1.8 % / zinc oxide 2 % ) Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530889 | Dynashield (dimethicone 1.8 % / zinc oxide 2 % ) Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530889 | Dynashield (dimethicone 1.8 % / zinc oxide 2 % ) Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530891 | Toxoplasma gondii DNA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2530892 | colloidal oatmeal 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2530893 | colloidal oatmeal 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2530893 | colloidal oatmeal 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2530893 | colloidal oatmeal 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253090 | methylsulfonylmethane 1000 MG / molybdenum 0.075 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253091 | mangafodipir 37.9 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531030 | zeaxanthin, meso- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531033 | glyceryl hydroxystearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2531034 | glyceryl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253109 | propylene glycol 5 % / polyethylene glycols 15 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253109 | propylene glycol 5 % / polyethylene glycols 15 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253109 | propylene glycol 5 % / polyethylene glycols 15 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253113 | busulfan 60 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253113 | busulfan 60 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253113 | busulfan 60 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531132 | Tsuga canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531133 | adalimumab starter pack 80 MG/0.8 ML Pen (4 count) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2531133 | adalimumab starter pack 80 MG/0.8 ML Pen (4 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531133 | adalimumab starter pack 80 MG/0.8 ML Pen (4 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531134 | Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2531134 | Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531134 | Humira Pen 80 MG/0.8 ML - Starter Package for Pediatric Ulcerative Colitis (4 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531135 | Diacronema lutheri preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531137 | Cylindrotheca fusiformis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253115 | hyaluronidase 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253115 | hyaluronidase 0.1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531274 | vitamin E acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2531280 | Zafemy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2531281 | ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR [Zafemy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2531282 | ethinyl estradiol / norelgestromin Transdermal System [Zafemy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2531283 | Zafemy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2531284 | Zafemy Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2531285 | ZAFEMY 150/35 MCG/Day Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2531285 | ZAFEMY 150/35 MCG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531285 | ZAFEMY 150/35 MCG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531286 | ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Zafemy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2531287 | fosdenopterin hydrobromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2531287 | fosdenopterin hydrobromide | Designated preferred name (PT) | YES | |
| RxCUI: 2531287 | fosdenopterin hydrobromide | Full form of descriptor (FN) | YES | |
| RxCUI: 2531288 | fosdenopterin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2531288 | fosdenopterin | Designated preferred name (PT) | YES | |
| RxCUI: 2531288 | fosdenopterin | Full form of descriptor (FN) | YES | |
| RxCUI: 2531288 | fosdenopterin | Designated preferred name (PT) | YES | |
| RxCUI: 2531288 | fosdenopterin | Full form of descriptor (FN) | YES | |
| RxCUI: 2531289 | fosdenopterin 9.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 253129 | petrolatum 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253129 | petrolatum 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253129 | petrolatum 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531290 | fosdenopterin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531290 | fosdenopterin Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2531290 | fosdenopterin Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2531291 | fosdenopterin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531292 | fosdenopterin 9.5 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 2531292 | fosdenopterin 9.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531292 | fosdenopterin 9.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531292 | fosdenopterin 9.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2531292 | fosdenopterin 9.5 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2531293 | Nulibry | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2531294 | fosdenopterin 9.5 MG [Nulibry] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2531295 | fosdenopterin Injection [Nulibry] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2531296 | Nulibry Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2531297 | Nulibry 9.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2531297 | Nulibry 9.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531297 | Nulibry 9.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531298 | propylene glycol 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2531299 | naphazoline hydrochloride 0.03 % / povidone 0.5 % / propylene glycol 0.2 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2531299 | naphazoline hydrochloride 0.03 % / povidone 0.5 % / propylene glycol 0.2 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531299 | naphazoline hydrochloride 0.03 % / povidone 0.5 % / propylene glycol 0.2 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531300 | povidone 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2531301 | naphazoline / povidone / propylene glycol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2531302 | naphazoline / povidone / propylene glycol Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2531303 | naphazoline / povidone / propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2531310 | Magnolia biondii flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531311 | rosmarinic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2531312 | rosmarinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253133 | shark liver oil 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253133 | shark liver oil 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253134 | shark liver oil 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253134 | shark liver oil 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253136 | caffeine 200 MG Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531367 | glucose 3750 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2531368 | glucose 3.75 GM Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531368 | glucose 3.75 GM Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531368 | glucose 3.75 GM Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531368 | glucose 3.75 GM Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2531369 | melphalan flufenamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2531369 | melphalan flufenamide | Designated preferred name (PT) | YES | |
| RxCUI: 2531369 | melphalan flufenamide | Full form of descriptor (FN) | YES | |
| RxCUI: 253137 | chondroitin sulfates 200 MG / glucosamine sulfate 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253137 | chondroitin sulfates 200 MG / glucosamine sulfate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531370 | melphalan flufenamide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2531370 | melphalan flufenamide hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2531370 | melphalan flufenamide hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2531371 | melphalan flufenamide 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2531372 | melphalan flufenamide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531373 | melphalan flufenamide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531374 | melphalan flufenamide 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531374 | melphalan flufenamide 20 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 2531374 | melphalan flufenamide 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531374 | melphalan flufenamide 20 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2531374 | melphalan flufenamide 20 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2531375 | Pepaxto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2531376 | melphalan flufenamide 20 MG [Pepaxto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2531377 | melphalan flufenamide Injection [Pepaxto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2531378 | Pepaxto Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2531379 | Pepaxto 20 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2531379 | Pepaxto 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531379 | Pepaxto 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531381 | zinc oxide 12.5 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531381 | zinc oxide 12.5 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2531381 | zinc oxide 12.5 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531381 | zinc oxide 12.5 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531382 | sulfur 42.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2531383 | sulfacetamide sodium 9 % / sulfur 4.25 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531383 | sulfacetamide sodium 9 % / sulfur 4.25 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2531384 | sulfacetamide sodium 90 MG/ML / sulfur 42.5 MG/ML [Clenia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2531385 | Clenia 9 % / 4.25 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531385 | Clenia 9 % / 4.25 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531385 | Clenia 9 % / 4.25 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2531386 | Aloysia citrodora leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253139 | glycolic acid 12 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 253139 | glycolic acid 12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 253139 | glycolic acid 12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253140 | petrolatum 43.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253140 | petrolatum 43.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 253140 | petrolatum 43.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253146 | Amfetamine- and dexamfetamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253146 | Amfetamine- and dexamfetamine-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 253146 | Amfetamine- and dexamfetamine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 253146 | Amfetamine- and dexamfetamine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Designated preferred name (PT) | YES | |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Full form of descriptor (FN) | YES | |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Designated preferred name (PT) | YES | |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Full form of descriptor (FN) | YES | |
| RxCUI: 253149 | Recombinant coagulation factor VIIa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253151 | recombinant antihemophilic factor VIII | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2531530 | aluminum acetate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2531531 | aluminum acetate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531532 | aluminum acetate 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2531532 | aluminum acetate 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2531532 | aluminum acetate 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2531534 | Lacticaseibacillus rhamnosus Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2531535 | inulin / Lacticaseibacillus rhamnosus | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2531536 | inulin / Lacticaseibacillus rhamnosus Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531537 | inulin / Lacticaseibacillus rhamnosus Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2531538 | Lacticaseibacillus rhamnosus Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531539 | Lacticaseibacillus rhamnosus / Limosilactobacillus reuteri Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2531540 | Lacticaseibacillus rhamnosus Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2531541 | Lacticaseibacillus rhamnosus / Limosilactobacillus reuteri Oral Capsule [Rephresh Pro-B] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2531542 | Lacticaseibacillus rhamnosus Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531543 | Lacticaseibacillus rhamnosus Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2531544 | Lacticaseibacillus rhamnosus / Limosilactobacillus reuteri | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2531545 | inulin / Lacticaseibacillus rhamnosus Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531546 | Lacticaseibacillus rhamnosus Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531547 | Lacticaseibacillus rhamnosus Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531548 | Lacticaseibacillus rhamnosus Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2531549 | Lacticaseibacillus rhamnosus / Limosilactobacillus reuteri Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 253155 | Azithromycin dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253155 | Azithromycin dihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 253155 | Azithromycin dihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 2531550 | Lacticaseibacillus rhamnosus Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531551 | inulin / Lacticaseibacillus rhamnosus Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531552 | Lacticaseibacillus rhamnosus / Limosilactobacillus reuteri Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2531553 | inulin / Lacticaseibacillus rhamnosus Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2531554 | Lacticaseibacillus rhamnosus Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2531555 | Lacticaseibacillus rhamnosus Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2531556 | Chrysanthemum indicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531557 | Chlorophytum borivilianum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253156 | Beclometasone dipropionate monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253156 | Beclometasone dipropionate monohydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 253156 | Beclometasone dipropionate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253156 | Beclometasone dipropionate monohydrate | Designated preferred name (PT) | YES | |
| RxCUI: 253157 | Bee pollen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253157 | Bee pollen | Designated preferred name (PT) | YES | |
| RxCUI: 253157 | Bee pollen | Full form of descriptor (FN) | YES | |
| RxCUI: 253158 | urea [14C] | Designated preferred name (PT) | YES | |
| RxCUI: 253158 | urea [14C] | Full form of descriptor (FN) | YES | |
| RxCUI: 253158 | urea [14C] | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253159 | chromium aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253160 | chromium, chelated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253161 | collagen hemostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253163 | dicalcium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253165 | didesmethyltocotrienol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253166 | synthetic conjugated estrogens, A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253168 | Garcinia cambogia preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253170 | Glucagon hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253170 | Glucagon hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 253170 | Glucagon hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 253172 | grape extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2531732 | salicylic acid 0.00001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2531733 | salicylic acid 0.001 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2531733 | salicylic acid 0.001 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2531733 | salicylic acid 0.001 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531734 | salicylic acid 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2531735 | salicylic acid 0.005 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2531735 | salicylic acid 0.005 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531735 | salicylic acid 0.005 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253181 | Human isophane insulin | Designated preferred name (PT) | YES | |
| RxCUI: 253181 | Human isophane insulin | Full form of descriptor (FN) | YES | |
| RxCUI: 253181 | Human isophane insulin | Designated preferred name (PT) | YES | |
| RxCUI: 253181 | Human isophane insulin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253181 | Human isophane insulin | Full form of descriptor (FN) | YES | |
| RxCUI: 253182 | Human insulin soluble | Designated preferred name (PT) | YES | |
| RxCUI: 253182 | Human insulin soluble | Full form of descriptor (FN) | YES | |
| RxCUI: 253182 | Human insulin soluble | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253182 | Human insulin soluble | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253182 | Human insulin soluble | Designated preferred name (PT) | YES | |
| RxCUI: 253182 | Human insulin soluble | Designated preferred name (PT) | YES | |
| RxCUI: 253182 | Human insulin soluble | Full form of descriptor (FN) | YES | |
| RxCUI: 253182 | Human insulin soluble | Designated preferred name (PT) | YES | |
| RxCUI: 253182 | Human insulin soluble | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 253182 | Human insulin soluble | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253182 | Human insulin soluble | Full form of descriptor (FN) | YES | |
| RxCUI: 253182 | Human insulin soluble | Full form of descriptor (FN) | YES | |
| RxCUI: 253183 | Humulin U Ultralente | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 253183 | Humulin U Ultralente | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 253185 | liver derivative complex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253186 | magnesium salicylate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 253187 | manganese aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253189 | Mixed vespid venom | Designated preferred name (PT) | NO | |
| RxCUI: 253189 | Mixed vespid venom | Full form of descriptor (FN) | NO | |
| RxCUI: 253190 | oat bran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253191 | Pantoprazole sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253191 | Pantoprazole sodium | Designated preferred name (PT) | YES | |
| RxCUI: 253191 | Pantoprazole sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 253192 | papaveretum hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 253193 | Passiflora incarnata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253193 | Passiflora incarnata extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253193 | Passiflora incarnata extract | Designated preferred name (PT) | NO | |
| RxCUI: 253193 | Passiflora incarnata extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2531930 | Armadillidium vulgare whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531931 | rice bran, defatted | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2531932 | petrolatum 540 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2531933 | petrolatum 54 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2531933 | petrolatum 54 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2531933 | petrolatum 54 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253198 | Rosiglitazone maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 253198 | Rosiglitazone maleate | Designated preferred name (PT) | NO | |
| RxCUI: 253198 | Rosiglitazone maleate | Full form of descriptor (FN) | NO | |
| RxCUI: 2532 | Chymotrypsin C | Designated preferred name (PT) | NO | |
| RxCUI: 2532 | Chymotrypsin C | Full form of descriptor (FN) | NO | |
| RxCUI: 253201 | squalene oil | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 253202 | tirofiban hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 253202 | tirofiban hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 253202 | tirofiban hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 253204 | trisodium citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253206 | Valerian extract | Designated preferred name (PT) | YES | |
| RxCUI: 253206 | Valerian extract | Full form of descriptor (FN) | YES | |
| RxCUI: 253206 | Valerian extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253206 | Valerian extract | Designated preferred name (PT) | YES | |
| RxCUI: 253206 | Valerian extract | Full form of descriptor (FN) | YES | |
| RxCUI: 253210 | zinc, chelated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253212 | thyroid (USP) 130 MG Oral Tablet [Natural Thyroid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253212 | thyroid (USP) 130 MG Oral Tablet [Natural Thyroid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2532159 | FLUoxetine 10 MG Oral Tablet (PMDD) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532159 | FLUoxetine 10 MG Oral Tablet (PMDD) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532159 | FLUoxetine 10 MG Oral Tablet (PMDD) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2532163 | FLUoxetine 20 MG Oral Tablet (PMDD) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532163 | FLUoxetine 20 MG Oral Tablet (PMDD) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532163 | FLUoxetine 20 MG Oral Tablet (PMDD) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2532167 | carboxymethylcellulose sodium 0.01 MG/MG [TheraTears] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532169 | carboxymethylcellulose sodium 0.0025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 253219 | Oxedrine | Designated preferred name (PT) | NO | |
| RxCUI: 253219 | Oxedrine | Full form of descriptor (FN) | NO | |
| RxCUI: 2532300 | ponesimod | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2532300 | ponesimod | Designated preferred name (PT) | YES | |
| RxCUI: 2532300 | ponesimod | Full form of descriptor (FN) | YES | |
| RxCUI: 2532300 | ponesimod | Designated preferred name (PT) | YES | |
| RxCUI: 2532300 | ponesimod | Full form of descriptor (FN) | YES | |
| RxCUI: 2532301 | ponesimod 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532302 | ponesimod Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2532302 | ponesimod Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2532302 | ponesimod Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2532303 | ponesimod Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2532304 | ponesimod Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2532305 | ponesimod 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532305 | ponesimod 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532305 | ponesimod 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532305 | ponesimod 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532306 | Ponvory | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2532307 | ponesimod 10 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532308 | ponesimod Oral Tablet [Ponvory] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2532309 | Ponvory Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2532310 | Ponvory Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2532311 | Ponvory 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532311 | Ponvory 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532311 | Ponvory 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532313 | ponesimod 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532314 | ponesimod 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532314 | ponesimod 2 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532314 | ponesimod 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532314 | ponesimod 2 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532315 | ponesimod 2 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532316 | Ponvory 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532316 | Ponvory 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532316 | Ponvory 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532317 | ponesimod 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532318 | ponesimod 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532318 | ponesimod 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532318 | ponesimod 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532318 | ponesimod 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532319 | ponesimod 20 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532320 | Ponvory 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532320 | Ponvory 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532320 | Ponvory 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532321 | ponesimod 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532322 | ponesimod 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532322 | ponesimod 3 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532322 | ponesimod 3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532322 | ponesimod 3 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532323 | ponesimod 3 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532324 | Ponvory 3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532324 | Ponvory 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532324 | Ponvory 3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532326 | ponesimod 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532327 | ponesimod 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532327 | ponesimod 4 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532327 | ponesimod 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532327 | ponesimod 4 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532328 | ponesimod 4 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532329 | Ponvory 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532329 | Ponvory 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532329 | Ponvory 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532330 | ponesimod 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532331 | ponesimod 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532331 | ponesimod 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532331 | ponesimod 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532331 | ponesimod 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532332 | ponesimod 5 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532333 | Ponvory 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532333 | Ponvory 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532333 | Ponvory 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532334 | ponesimod 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532335 | ponesimod 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532335 | ponesimod 6 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532335 | ponesimod 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532335 | ponesimod 6 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532336 | ponesimod 6 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532337 | Ponvory 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532337 | Ponvory 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532337 | Ponvory 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532338 | ponesimod 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532339 | ponesimod 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532339 | ponesimod 7 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532339 | ponesimod 7 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532339 | ponesimod 7 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532340 | ponesimod 7 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532341 | Ponvory 7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532341 | Ponvory 7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532341 | Ponvory 7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532342 | ponesimod 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532343 | ponesimod 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532343 | ponesimod 8 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532343 | ponesimod 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532343 | ponesimod 8 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532344 | ponesimod 8 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532345 | Ponvory 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532345 | Ponvory 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532345 | Ponvory 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532346 | ponesimod 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532347 | ponesimod 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532347 | ponesimod 9 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2532347 | ponesimod 9 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532347 | ponesimod 9 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2532348 | ponesimod 9 MG [Ponvory] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532349 | Ponvory 9 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2532349 | Ponvory 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532349 | Ponvory 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532350 | ponesimod 14 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2532350 | ponesimod 14 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532350 | ponesimod 14 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532351 | Ponvory 14 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2532351 | Ponvory 14 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532351 | Ponvory 14 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532353 | dimer dilinoleyl diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2532360 | oritavancin 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2532361 | oritavancin 1200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532361 | oritavancin 1200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532361 | oritavancin 1200 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2532362 | Kimyrsa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2532363 | oritavancin 1200 MG [Kimyrsa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2532364 | oritavancin Injection [Kimyrsa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2532365 | Kimyrsa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2532366 | Kimyrsa 1200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532366 | Kimyrsa 1200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2532366 | Kimyrsa 1200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2532366 | Kimyrsa 1200 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 253239 | Cyclospasmol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 253240 | Epodyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 253243 | Telepaque | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2532518 | coal tar 20 MG/ML [Psoriasin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2532519 | coal tar Medicated Liquid Soap [Psoriasin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2532520 | Psoriasin Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2532521 | Psoriasin 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2532521 | Psoriasin 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2532521 | Psoriasin 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532521 | Psoriasin 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532522 | Mal-A-Ket Wipes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2532523 | chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML [Mal-A-Ket Wipes] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2532524 | chlorhexidine / ketoconazole Medicated Pad [Mal-A-Ket Wipes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2532525 | Mal-A-Ket Wipes Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2532526 | Mal-A-Ket Wipes Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2532527 | Mal-A-Ket Wipes 2 % / 1 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2532527 | Mal-A-Ket Wipes 2 % / 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532527 | Mal-A-Ket Wipes 2 % / 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2532528 | Sedexodine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2532529 | dexmedetomidine hydrochloride 0.5 MG/ML [Sedexodine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2532529 | dexmedetomidine hydrochloride 0.5 MG/ML [Sedexodine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2532530 | dexmedetomidine Injectable Solution [Sedexodine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2532530 | dexmedetomidine Injectable Solution [Sedexodine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2532531 | Sedexodine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2532532 | Sedexodine 0.5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2532532 | Sedexodine 0.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2532532 | Sedexodine 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2532532 | Sedexodine 0.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532533 | Mitchella repens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2532534 | Lissamine green B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2532534 | Lissamine green B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532534 | Lissamine green B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532534 | Lissamine green B | Designated preferred name (PT) | NO | |
| RxCUI: 2532534 | Lissamine green B | Full form of descriptor (FN) | NO | |
| RxCUI: 2532534 | Lissamine green B | Designated preferred name (PT) | NO | |
| RxCUI: 2532534 | Lissamine green B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532534 | Lissamine green B | Full form of descriptor (FN) | NO | |
| RxCUI: 2532534 | Lissamine green B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532536 | bis-diglyceryl polyacyladipate-1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253261 | Nupercainal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2532930 | Astragalus canadensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2532931 | Astragalus mongholicus root polysaccharides | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532931 | Astragalus mongholicus root polysaccharides | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2532931 | Astragalus mongholicus root polysaccharides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533030 | Caladium bicolor whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533031 | polyglyceryl-6 caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2533130 | Ranunculus bulbosus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533230 | Vigna radiata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533331 | salicylic acid 4.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2533332 | salicylic acid 0.46 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2533332 | salicylic acid 0.46 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533332 | salicylic acid 0.46 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 253337 | bevacizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 253337 | bevacizumab | Designated preferred name (PT) | YES | |
| RxCUI: 253337 | bevacizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 253337 | bevacizumab | Designated preferred name (PT) | YES | |
| RxCUI: 253337 | bevacizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 253341 | 125-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 253341 | 125-I | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 253341 | 125-I | Designated preferred name (PT) | NO | |
| RxCUI: 253341 | 125-I | Full form of descriptor (FN) | NO | |
| RxCUI: 253341 | 125-I | Designated preferred name (PT) | NO | |
| RxCUI: 253341 | 125-I | Full form of descriptor (FN) | NO | |
| RxCUI: 2533431 | phenylephrine hydrochloride 0.1 MG/ML [Biorphen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2533432 | phenylephrine Injection [Biorphen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2533433 | Biorphen Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2533434 | Biorphen 500 MCG in 5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2533434 | Biorphen 500 MCG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2533434 | Biorphen 500 MCG in 5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2533434 | Biorphen 500 MCG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2533435 | phenylephrine hydrochloride 0.1 MG/ML Injection [Biorphen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533435 | phenylephrine hydrochloride 0.1 MG/ML Injection [Biorphen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2533436 | phenylephrine hydrochloride 10 MG/ML [Biorphen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2533437 | Biorphen 10 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2533437 | Biorphen 10 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2533437 | Biorphen 10 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2533438 | phenylephrine hydrochloride 10 MG/ML Injection [Biorphen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533438 | phenylephrine hydrochloride 10 MG/ML Injection [Biorphen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25338 | Fructokinase | Designated preferred name (PT) | NO | |
| RxCUI: 25338 | Fructokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 2533830 | Agastache urticifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533831 | Angelica archangelica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533832 | arsenic trichloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533833 | Artemisia tridentata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533834 | Briza maxima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533835 | Calochortus gunnisonii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533836 | Calochortus tolmiei whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533837 | 2-octyl cyanoacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533837 | 2-octyl cyanoacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 2533837 | 2-octyl cyanoacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 2533837 | 2-octyl cyanoacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 2533837 | 2-octyl cyanoacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 2533838 | Diisononyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533845 | Ceanothus integerrimus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533846 | Centaurea solstitialis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533847 | Chaenomeles lagenaria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533848 | Consolida regalis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533849 | Cornus nuttallii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533851 | Cotinus coggygria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533852 | Dicentra formosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533854 | Diplacus aurantiacus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533856 | Ehrendorferia chrysantha whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533857 | Ericameria nauseosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533858 | Eriobotrya japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533859 | ethyl thioglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533896 | Primula hendersonii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533898 | Madia elegans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533899 | Mimulus ringens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533901 | Monardella odoratissima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533902 | Penstemon davidsonii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533903 | Clinicalm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2533904 | hydrocortisone 10 MG/ML [Clinicalm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2533905 | hydrocortisone Topical Cream [Clinicalm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2533906 | Clinicalm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2533907 | CliniCalm 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2533907 | CliniCalm 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533907 | CliniCalm 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2533908 | Persea americana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533909 | Prunella vulgaris flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533910 | Prunus persica var. nucipersica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533911 | Rosa californica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533912 | Salix repens pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533913 | Silene laciniata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533914 | Toxicodendron diversilobum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533915 | Tradescantia occidentalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533916 | Tsuga canadensis leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2533917 | Viola odorata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533918 | Zinnia elegans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533919 | lincomycin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2533920 | lincomycin 3000 MG in 10 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2533920 | lincomycin 3000 MG in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533920 | lincomycin 3000 MG in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2533921 | lincomycin 300 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2533922 | lauralkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2533923 | Lauralkonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2533923 | Lauralkonium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2533925 | salicylic acid 3 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2533925 | salicylic acid 3 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2533925 | salicylic acid 3 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534158 | Diaperene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2534159 | zinc oxide 130 MG/ML [Diaperene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534160 | zinc oxide Topical Cream [Diaperene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2534161 | Diaperene Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2534162 | Diaperene 13 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534162 | Diaperene 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534162 | Diaperene 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534162 | Diaperene 13 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534162 | Diaperene 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534163 | zinc oxide 400 MG/ML [Diaperene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534164 | Diaperene 40 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534164 | Diaperene 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534164 | Diaperene 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534164 | Diaperene 40 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534164 | Diaperene 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534165 | camphor 3 % / menthol 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534165 | camphor 3 % / menthol 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534165 | camphor 3 % / menthol 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2534180 | Diaperene Adult | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2534181 | menthol 0.0044 MG/MG / zinc oxide 0.206 MG/MG [Diaperene Adult] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534182 | menthol / zinc oxide Topical Ointment [Diaperene Adult] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2534183 | Diaperene Adult Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2534184 | Diaperene Adult 0.44 % / 20. 6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534184 | Diaperene Adult 0.44 % / 20. 6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534184 | Diaperene Adult 0.44 % / 20. 6 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534184 | Diaperene Adult 0.44 % / 20. 6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534230 | chlorhexidine / miconazole Medicated Shampoo [MiconaHex+Triz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2534231 | MiconaHex+Triz Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2534232 | MiconaHex+Triz 2 % / 2 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534232 | MiconaHex+Triz 2 % / 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534232 | MiconaHex+Triz 2 % / 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534233 | Tivozanib | Full form of descriptor (FN) | YES | |
| RxCUI: 2534233 | Tivozanib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534233 | Tivozanib | Designated preferred name (PT) | YES | |
| RxCUI: 2534233 | Tivozanib | Full form of descriptor (FN) | YES | |
| RxCUI: 2534233 | Tivozanib | Designated preferred name (PT) | YES | |
| RxCUI: 2534234 | tivozanib 0.89 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2534235 | Product containing tivozanib in oral dose form (medicinal product form) | Full form of descriptor (FN) | YES | |
| RxCUI: 2534235 | Product containing tivozanib in oral dose form (medicinal product form) | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2534235 | Product containing tivozanib in oral dose form (medicinal product form) | Designated preferred name (PT) | YES | |
| RxCUI: 2534236 | tivozanib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2534237 | tivozanib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2534238 | tivozanib 0.89 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2534238 | tivozanib 0.89 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534238 | tivozanib 0.89 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2534238 | tivozanib 0.89 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2534238 | tivozanib 0.89 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2534239 | Fotivda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2534240 | tivozanib 0.89 MG [Fotivda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2534241 | tivozanib Oral Capsule [Fotivda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2534242 | Fotivda Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2534243 | Fotivda Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2534244 | FOTIVDA 0.89 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534244 | FOTIVDA 0.89 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2534244 | FOTIVDA 0.89 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534244 | FOTIVDA 0.89 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2534245 | tivozanib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2534245 | tivozanib hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 2534245 | tivozanib hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2534246 | tivozanib 1.34 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2534247 | tivozanib 1.34 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2534247 | tivozanib 1.34 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534247 | tivozanib 1.34 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2534247 | tivozanib 1.34 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2534247 | tivozanib 1.34 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2534248 | tivozanib 1.34 MG [Fotivda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2534249 | FOTIVDA 1.34 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534249 | FOTIVDA 1.34 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2534249 | FOTIVDA 1.34 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534249 | FOTIVDA 1.34 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 25343 | 5-keto-D-fructose reductase (NADP^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25343 | 5-keto-D-fructose reductase (NADP^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 25343 | 5-keto-D-fructose reductase (NADP^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25343 | 5-keto-D-fructose reductase (NADP^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 2534330 | epinephrine / lidocaine / tetracaine Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2534330 | epinephrine / lidocaine / tetracaine Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2534331 | epinephrine / lidocaine / tetracaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2534331 | epinephrine / lidocaine / tetracaine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2534332 | epinephrine / lidocaine / tetracaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2534332 | epinephrine / lidocaine / tetracaine Topical Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2534333 | EPINEPHrine 0.1 % / lidocaine HCl 5 % / tetracaine HCl 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2534333 | EPINEPHrine 0.1 % / lidocaine HCl 5 % / tetracaine HCl 1 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2534333 | EPINEPHrine 0.1 % / lidocaine HCl 5 % / tetracaine HCl 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534333 | EPINEPHrine 0.1 % / lidocaine HCl 5 % / tetracaine HCl 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534333 | EPINEPHrine 0.1 % / lidocaine HCl 5 % / tetracaine HCl 1 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2534334 | tetracaine hydrochloride 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2534440 | Curcuma aromatica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534441 | N-vinylcaprolactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534442 | PEG-175 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534443 | PEG-9 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534444 | polyglyceryl-6 ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534445 | PPG-8-ceteth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534446 | sodium triethanolamine tris(dihydrogen phosphate) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2534447 | sorbeth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2534448 | strontium bromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534453 | Asimina triloba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534454 | benzo(A)pyrene | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534454 | benzo(A)pyrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534455 | Campsis radicans flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534456 | Carnegiea gigantea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534457 | Coffea arabica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534458 | Erythranthe cardinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534459 | Fuchsia magellanica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534460 | lead chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534462 | Sequoia sempervirens bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534463 | sulfonmethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534464 | Trichloroethylene | Full form of descriptor (FN) | NO | |
| RxCUI: 2534464 | Trichloroethylene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534464 | Trichloroethylene | Designated preferred name (PT) | NO | |
| RxCUI: 2534464 | Trichloroethylene | Full form of descriptor (FN) | NO | |
| RxCUI: 2534464 | Trichloroethylene | Designated preferred name (PT) | NO | |
| RxCUI: 2534465 | Trillium chloropetalum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534466 | Veronica beccabunga whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2534467 | Milbehart | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2534468 | milbemycin oxime 2.3 MG [Milbehart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534469 | milbemycin oxime Oral Tablet [Milbehart] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2534470 | Milbehart Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2534471 | Milbehart Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2534472 | Milbehart 2.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534472 | Milbehart 2.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534472 | Milbehart 2.3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534473 | milbemycin oxime 11.5 MG [Milbehart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534474 | Milbehart 11.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534474 | Milbehart 11.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534474 | Milbehart 11.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534475 | milbemycin oxime 5.75 MG [Milbehart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534476 | Milbehart 5.75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534476 | Milbehart 5.75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534476 | Milbehart 5.75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534477 | milbemycin oxime 23 MG [Milbehart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2534478 | Milbehart 23 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534478 | Milbehart 23 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534478 | Milbehart 23 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2534479 | magnesium glycinate 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2534480 | magnesium glycinate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2534481 | magnesium (as magnesium glycinate chelate) 120 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534481 | magnesium (as magnesium glycinate chelate) 120 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534481 | magnesium (as magnesium glycinate chelate) 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2534482 | methyl salicylate 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2534482 | methyl salicylate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2534482 | methyl salicylate 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25345 | Fructose-1-phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 25345 | Fructose-1-phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 253453 | Peginterferon alfa-2b | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 253453 | Peginterferon alfa-2b | Designated preferred name (PT) | NO | |
| RxCUI: 253453 | Peginterferon alfa-2b | Full form of descriptor (FN) | NO | |
| RxCUI: 253453 | Peginterferon alfa-2b | Designated preferred name (PT) | NO | |
| RxCUI: 253453 | Peginterferon alfa-2b | Full form of descriptor (FN) | NO | |
| RxCUI: 25346 | Fructose-2,6-bisphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 25346 | Fructose-2,6-bisphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 25348 | Fructose-6-phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 25348 | Fructose-6-phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2535230 | ethanol 0.703 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2535231 | ethanol 70.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535231 | ethanol 70.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535231 | ethanol 70.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535232 | ethanol 70.3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535232 | ethanol 70.3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535232 | ethanol 70.3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535233 | dasiglucagon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2535234 | dasiglucagon hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2535235 | dasiglucagon 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2535236 | dasiglucagon Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2535237 | dasiglucagon Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2535238 | dasiglucagon 0.6 MG in 0.6 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535238 | dasiglucagon 0.6 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535238 | dasiglucagon 0.6 MG in 0.6 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535238 | dasiglucagon 0.6 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535239 | Zegalogue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2535240 | dasiglucagon 1 MG/ML [Zegalogue] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2535241 | dasiglucagon Prefilled Syringe [Zegalogue] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2535242 | Zegalogue Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2535243 | ZEGALOGUE 0.6 MG in 0.6 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2535243 | ZEGALOGUE 0.6 MG in 0.6 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535243 | ZEGALOGUE 0.6 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535243 | ZEGALOGUE 0.6 MG in 0.6 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535244 | dasiglucagon 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535245 | dasiglucagon 1 MG/ML Prefilled Syringe [Zegalogue] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2535245 | dasiglucagon 1 MG/ML Prefilled Syringe [Zegalogue] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535246 | dasiglucagon Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2535247 | dasiglucagon 0.6 MG in 0.6 mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535247 | dasiglucagon 0.6 MG in 0.6 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535247 | dasiglucagon 0.6 MG in 0.6 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535247 | dasiglucagon 0.6 MG in 0.6 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535248 | dasiglucagon Auto-Injector [Zegalogue] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2535249 | ZEGALOGUE 0.6 MG in 0.6 mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2535249 | ZEGALOGUE 0.6 MG in 0.6 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535249 | ZEGALOGUE 0.6 MG in 0.6 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535249 | ZEGALOGUE 0.6 MG in 0.6 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535250 | dasiglucagon 1 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535251 | dasiglucagon 1 MG/ML Auto-Injector [Zegalogue] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2535251 | dasiglucagon 1 MG/ML Auto-Injector [Zegalogue] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535252 | Dexased | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2535253 | dexmedetomidine hydrochloride 0.5 MG/ML [Dexased] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2535253 | dexmedetomidine hydrochloride 0.5 MG/ML [Dexased] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2535254 | dexmedetomidine Injectable Solution [Dexased] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2535254 | dexmedetomidine Injectable Solution [Dexased] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2535255 | Dexased Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2535256 | DEXASED 0.5 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535256 | DEXASED 0.5 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535256 | DEXASED 0.5 MG/mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2535256 | DEXASED 0.5 MG/mL Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2535257 | glyceryl 1,3-dibehenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2535258 | Glycosmis citrifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2535259 | Lolium perenne top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2535499 | potassium permanganate 51.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2535500 | potassium permanganate 5.12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535500 | potassium permanganate 5.12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535500 | potassium permanganate 5.12 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535500 | potassium permanganate 5.12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535500 | potassium permanganate 5.12 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535502 | hydroxypropyl cellulose (20000 WAMW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2535503 | Melaleuca cajuputi whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2535510 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535510 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535510 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25357 | follitropin beta | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 25357 | follitropin beta | Designated preferred name (PT) | YES | |
| RxCUI: 25357 | follitropin beta | Full form of descriptor (FN) | YES | |
| RxCUI: 25357 | follitropin beta | Designated preferred name (PT) | YES | |
| RxCUI: 25357 | follitropin beta | Full form of descriptor (FN) | YES | |
| RxCUI: 2535738 | camphor 10 % / menthol 8 % / methyl salicylate 25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2535738 | camphor 10 % / menthol 8 % / methyl salicylate 25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2535738 | camphor 10 % / menthol 8 % / methyl salicylate 25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2535744 | ezetimibe / rosuvastatin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2535744 | ezetimibe / rosuvastatin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2535744 | ezetimibe / rosuvastatin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2535745 | ezetimibe 10 MG / rosuvastatin 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535745 | ezetimibe 10 MG / rosuvastatin 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535745 | ezetimibe 10 MG / rosuvastatin 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535746 | ezetimibe / rosuvastatin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2535747 | ezetimibe 10 MG / rosuvastatin 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535747 | ezetimibe 10 MG / rosuvastatin 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535747 | ezetimibe 10 MG / rosuvastatin 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535748 | ezetimibe / rosuvastatin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2535748 | ezetimibe / rosuvastatin | Designated preferred name (PT) | YES | |
| RxCUI: 2535748 | ezetimibe / rosuvastatin | Full form of descriptor (FN) | YES | |
| RxCUI: 2535749 | ezetimibe 10 MG / rosuvastatin 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535749 | ezetimibe 10 MG / rosuvastatin 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535749 | ezetimibe 10 MG / rosuvastatin 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535750 | ezetimibe 10 MG / rosuvastatin 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2535750 | ezetimibe 10 MG / rosuvastatin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2535750 | ezetimibe 10 MG / rosuvastatin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2535751 | ezetimibe / rosuvastatin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2536055 | Roszet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2536056 | ezetimibe 10 MG / rosuvastatin 10 MG [Roszet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536057 | ezetimibe / rosuvastatin Oral Tablet [Roszet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2536058 | Roszet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2536059 | Roszet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2536060 | Roszet 10 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536060 | Roszet 10 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536060 | Roszet 10 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536061 | ezetimibe 10 MG / rosuvastatin 20 MG [Roszet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536062 | Roszet 20 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536062 | Roszet 20 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536062 | Roszet 20 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536063 | ezetimibe 10 MG / rosuvastatin 40 MG [Roszet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536064 | Roszet 40 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536064 | Roszet 40 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536064 | Roszet 40 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536065 | ezetimibe 10 MG / rosuvastatin 5 MG [Roszet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536066 | Roszet 5 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536066 | Roszet 5 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536066 | Roszet 5 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536136 | Trifolium arvense whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2536137 | Cassia javanica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2536141 | salicylic acid 170 MG/ML [Verruguin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2536142 | salicylic acid Topical Solution [Verruguin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2536143 | Verruguin 170 MG/mL Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536143 | Verruguin 170 MG/mL Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2536143 | Verruguin 170 MG/mL Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536230 | benzocaine 2 % / ethanol 50 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2536230 | benzocaine 2 % / ethanol 50 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536230 | benzocaine 2 % / ethanol 50 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536330 | methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536330 | methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2536330 | methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25364 | Fucokinase | Designated preferred name (PT) | NO | |
| RxCUI: 25364 | Fucokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 2536430 | idecabtagene vicleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2536430 | idecabtagene vicleucel | Designated preferred name (PT) | YES | |
| RxCUI: 2536430 | idecabtagene vicleucel | Full form of descriptor (FN) | YES | |
| RxCUI: 2536430 | idecabtagene vicleucel | Designated preferred name (PT) | YES | |
| RxCUI: 2536430 | idecabtagene vicleucel | Full form of descriptor (FN) | YES | |
| RxCUI: 2536431 | idecabtagene vicleucel 15333333 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536432 | idecabtagene vicleucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2536432 | idecabtagene vicleucel Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2536432 | idecabtagene vicleucel Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2536433 | idecabtagene vicleucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2536434 | idecabtagene vicleucel 460000000 CELLS in 30 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536434 | idecabtagene vicleucel 460000000 CELLS in 30 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536434 | idecabtagene vicleucel 460000000 CELLS in 30 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536434 | idecabtagene vicleucel 460000000 CELLS in 30 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536435 | Abecma | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2536436 | idecabtagene vicleucel 15333333 CELLS/ML [Abecma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536437 | idecabtagene vicleucel Injection [Abecma] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2536438 | Abecma Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2536439 | Abecma 460000000 CELLS in 30 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536439 | Abecma 460000000 CELLS in 30 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536439 | Abecma 460000000 CELLS in 30 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536439 | Abecma 460000000 CELLS in 30 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536440 | idecabtagene vicleucel 15333333 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536441 | idecabtagene vicleucel 15333333 CELLS/ML Injection [Abecma] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536441 | idecabtagene vicleucel 15333333 CELLS/ML Injection [Abecma] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536442 | idecabtagene vicleucel 6571428 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536443 | idecabtagene vicleucel 460000000 CELLS in 70 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536443 | idecabtagene vicleucel 460000000 CELLS in 70 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536443 | idecabtagene vicleucel 460000000 CELLS in 70 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536443 | idecabtagene vicleucel 460000000 CELLS in 70 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536444 | idecabtagene vicleucel 6571428 CELLS/ML [Abecma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536445 | Abecma 460000000 CELLS in 70 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536445 | Abecma 460000000 CELLS in 70 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536445 | Abecma 460000000 CELLS in 70 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536445 | Abecma 460000000 CELLS in 70 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536446 | idecabtagene vicleucel 6571428 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536447 | idecabtagene vicleucel 6571428 CELLS/ML Injection [Abecma] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536447 | idecabtagene vicleucel 6571428 CELLS/ML Injection [Abecma] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536448 | idecabtagene vicleucel 4600000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536449 | idecabtagene vicleucel 460000000 CELLS in 100 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536449 | idecabtagene vicleucel 460000000 CELLS in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536449 | idecabtagene vicleucel 460000000 CELLS in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536449 | idecabtagene vicleucel 460000000 CELLS in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536450 | idecabtagene vicleucel 4600000 CELLS/ML [Abecma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536451 | Abecma 460000000 CELLS in 100 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536451 | Abecma 460000000 CELLS in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536451 | Abecma 460000000 CELLS in 100 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536451 | Abecma 460000000 CELLS in 100 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536452 | idecabtagene vicleucel 4600000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536453 | idecabtagene vicleucel 4600000 CELLS/ML Injection [Abecma] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536453 | idecabtagene vicleucel 4600000 CELLS/ML Injection [Abecma] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536542 | Lactobacillus acidophilus 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536543 | Lactobacillus acidophilus 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536543 | Lactobacillus acidophilus 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536547 | viloxazine Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2536548 | viloxazine 100 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536548 | viloxazine 100 MG 24HR Extended Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2536548 | viloxazine 100 MG 24HR Extended Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2536548 | viloxazine 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536548 | viloxazine 100 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536549 | Qelbree | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2536550 | viloxazine 100 MG [Qelbree] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536551 | viloxazine Extended Release Oral Capsule [Qelbree] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2536552 | Qelbree Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2536553 | Qelbree Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2536554 | Qelbree 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536554 | Qelbree 100 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536554 | Qelbree 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536554 | Qelbree 100 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536555 | viloxazine 100 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536556 | viloxazine 100 MG Extended Release Oral Capsule [Qelbree] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536556 | viloxazine 100 MG Extended Release Oral Capsule [Qelbree] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536738 | witch hazel 20 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536738 | witch hazel 20 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536738 | witch hazel 20 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536739 | baloxavir marboxil 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536740 | baloxavir marboxil 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536740 | baloxavir marboxil 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536741 | baloxavir marboxil 80 MG [Xofluza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536742 | Xofluza 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536742 | Xofluza 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536742 | Xofluza 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536749 | viloxazine 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536750 | 24HR viloxazine 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536750 | 24HR viloxazine 150 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536750 | 24HR viloxazine 150 MG Extended Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2536750 | 24HR viloxazine 150 MG Extended Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2536751 | viloxazine 150 MG [Qelbree] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536752 | Qelbree 150 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536752 | Qelbree 150 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536752 | Qelbree 150 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536752 | Qelbree 150 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536753 | viloxazine 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536754 | viloxazine 150 MG Extended Release Oral Capsule [Qelbree] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536755 | viloxazine 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2536756 | 24HR viloxazine 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2536756 | 24HR viloxazine 200 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536756 | 24HR viloxazine 200 MG Extended Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2536756 | 24HR viloxazine 200 MG Extended Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2536757 | viloxazine 200 MG [Qelbree] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2536758 | Qelbree 200 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536758 | Qelbree 200 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2536758 | Qelbree 200 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2536758 | Qelbree 200 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2536759 | viloxazine 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2536760 | viloxazine 200 MG Extended Release Oral Capsule [Qelbree] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2536760 | viloxazine 200 MG Extended Release Oral Capsule [Qelbree] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2536937 | octamethyltetrasiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2536938 | Peptostreptococcus anaerobius DNA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537433 | disodium zinc edetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537434 | glycereth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537435 | quaternium-90 montmorillonite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537436 | quaternium-90 sepiolite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537437 | Sasa kurilensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537630 | quaternium-15 trans-form | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2537631 | progesterone 0.458 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2537632 | progesterone Vaginal System | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2537633 | progesterone 11 MG per 24HR 7 Day Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2537633 | progesterone 11 MG per 24HR 7 Day Vaginal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2537633 | progesterone 11 MG per 24HR 7 Day Vaginal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2537634 | progesterone 0.458 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2537730 | miconazole nitrate 20 MG/ML [DermaFungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2537731 | miconazole Topical Cream [DermaFungal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2537732 | DermaFungal 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2537732 | DermaFungal 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2537732 | DermaFungal 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2537732 | DermaFungal 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 25380 | Fullers earth | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25380 | Fullers earth | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25380 | Fullers earth | Designated preferred name (PT) | NO | |
| RxCUI: 25380 | Fullers earth | Full form of descriptor (FN) | NO | |
| RxCUI: 25380 | Fullers earth | Designated preferred name (PT) | NO | |
| RxCUI: 25380 | Fullers earth | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 25380 | Fullers earth | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25380 | Fullers earth | Full form of descriptor (FN) | NO | |
| RxCUI: 25387 | Fumarate reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
| RxCUI: 25387 | Fumarate reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25387 | Fumarate reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
| RxCUI: 2538830 | minoxidil 20 MG/ML [Regoxidine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2538831 | minoxidil Topical Solution [Regoxidine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2538832 | Regoxidine 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2538832 | Regoxidine 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2538832 | Regoxidine 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2538832 | Regoxidine 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2538833 | chlorhexidine / ketoconazole Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2538834 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2538834 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2538834 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2538837 | hydrocortisone / ketoconazole Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2538838 | hydrocortisone 1 % / ketoconazole 0.15 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2538838 | hydrocortisone 1 % / ketoconazole 0.15 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2538838 | hydrocortisone 1 % / ketoconazole 0.15 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25389 | fumaric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2539030 | cetyl glyceryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539031 | estetrol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2539031 | estetrol | Designated preferred name (PT) | YES | |
| RxCUI: 2539031 | estetrol | Full form of descriptor (FN) | YES | |
| RxCUI: 2539032 | Nextstellis 28 Day | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2539032 | Nextstellis 28 Day | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539032 | Nextstellis 28 Day | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539033 | drospirenone 3 MG / estetrol 14.2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539033 | drospirenone 3 MG / estetrol 14.2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539033 | drospirenone 3 MG / estetrol 14.2 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2539033 | drospirenone 3 MG / estetrol 14.2 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2539034 | drospirenone / estetrol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539034 | drospirenone / estetrol Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2539034 | drospirenone / estetrol Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2539035 | estetrol monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2539035 | estetrol monohydrate | Designated preferred name (PT) | YES | |
| RxCUI: 2539035 | estetrol monohydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 2539036 | drospiren-estetrol 3-14.2 MG (24) Oral Tablet / Inert 1 MG (4) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2539036 | drospiren-estetrol 3-14.2 MG (24) Oral Tablet / Inert 1 MG (4) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539037 | drospirenone / estetrol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2539037 | drospirenone / estetrol | Designated preferred name (PT) | YES | |
| RxCUI: 2539037 | drospirenone / estetrol | Full form of descriptor (FN) | YES | |
| RxCUI: 2539038 | drospirenone / estetrol Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2539039 | drospirenone / estetrol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539040 | estetrol 14.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2539169 | hydrolyzed sheep wool keratin (200 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539170 | human embryo tissue preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539171 | Human plasma preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539171 | Human plasma preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539171 | Human plasma preparation | Designated preferred name (PT) | NO | |
| RxCUI: 2539171 | Human plasma preparation | Full form of descriptor (FN) | NO | |
| RxCUI: 2539172 | Picrotoxin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539172 | Picrotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2539172 | Picrotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2539173 | polyglyceryl-3 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539174 | Ranunculus glacialis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539174 | Ranunculus glacialis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539175 | N,N,N-(2-Trimethylammonio) ethyl methacrylate chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539175 | N,N,N-(2-Trimethylammonio) ethyl methacrylate chloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539176 | triamcinolone hexacetonide 40 MG in 2 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539176 | triamcinolone hexacetonide 40 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539176 | triamcinolone hexacetonide 40 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539177 | Hexatrione | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2539178 | triamcinolone hexacetonide 20 MG/ML [Hexatrione] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2539179 | triamcinolone Injection [Hexatrione] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2539180 | Hexatrione Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2539181 | Hexatrione 40 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539181 | Hexatrione 40 MG in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539181 | Hexatrione 40 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539181 | Hexatrione 40 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539182 | triamcinolone hexacetonide 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539183 | Hexatrione 20 MG/mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539183 | Hexatrione 20 MG/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539183 | Hexatrione 20 MG/mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539184 | ferrous gluconate 225 MG [Fergon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2539185 | Fergon 225 MG (iron 27 MG) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539185 | Fergon 225 MG (iron 27 MG) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539185 | Fergon 225 MG (iron 27 MG) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539185 | Fergon 225 MG (iron 27 MG) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539186 | meperidine HCl 50 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539186 | meperidine HCl 50 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539186 | meperidine HCl 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539186 | meperidine HCl 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539187 | meperidine Prefilled Syringe [Demerol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2539188 | Demerol 50 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539188 | Demerol 50 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539188 | Demerol 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539188 | Demerol 50 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539189 | meperidine hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539190 | meperidine hydrochloride 50 MG/ML Prefilled Syringe [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539190 | meperidine hydrochloride 50 MG/ML Prefilled Syringe [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539191 | meperidine HCl 25 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539191 | meperidine HCl 25 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539191 | meperidine HCl 25 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539191 | meperidine HCl 25 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539192 | Demerol 25 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539192 | Demerol 25 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539192 | Demerol 25 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539192 | Demerol 25 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539193 | meperidine hydrochloride 25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539194 | meperidine hydrochloride 25 MG/ML Prefilled Syringe [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539194 | meperidine hydrochloride 25 MG/ML Prefilled Syringe [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539195 | meperidine HCl 100 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539195 | meperidine HCl 100 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539195 | meperidine HCl 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539195 | meperidine HCl 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539196 | Demerol 100 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539196 | Demerol 100 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539196 | Demerol 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539196 | Demerol 100 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539197 | meperidine hydrochloride 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539198 | meperidine hydrochloride 100 MG/ML Prefilled Syringe [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539198 | meperidine hydrochloride 100 MG/ML Prefilled Syringe [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539199 | meperidine HCl 75 MG in 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539199 | meperidine HCl 75 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539199 | meperidine HCl 75 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539199 | meperidine HCl 75 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25392 | Beta-diketonase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25392 | Beta-diketonase | Designated preferred name (PT) | NO | |
| RxCUI: 25392 | Beta-diketonase | Full form of descriptor (FN) | NO | |
| RxCUI: 25392 | Beta-diketonase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539200 | Demerol 75 MG in 1 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539200 | Demerol 75 MG in 1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539200 | Demerol 75 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539200 | Demerol 75 MG in 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539201 | meperidine hydrochloride 75 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539202 | meperidine hydrochloride 75 MG/ML Prefilled Syringe [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539202 | meperidine hydrochloride 75 MG/ML Prefilled Syringe [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539206 | mannose 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2539207 | mannose 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539207 | mannose 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539208 | salicylic acid 139 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2539209 | salicylic acid 13.9 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539209 | salicylic acid 13.9 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539209 | salicylic acid 13.9 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539222 | ethinyl estradiol / levonorgestrel Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539223 | ethinyl estradiol / levonorgestrel Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2539224 | ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539224 | ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539225 | inert ingredients Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539226 | inert ingredients Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2539227 | inert ingredients 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539227 | inert ingredients 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539228 | Eth estra-Levonorgest 0.02-0.1 MG (21) Chewable Tablet / Inert 1 MG (7) Chewable Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2539228 | Eth estra-Levonorgest 0.02-0.1 MG (21) Chewable Tablet / Inert 1 MG (7) Chewable Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539280 | lotilaner 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539281 | lotilaner 12 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539281 | lotilaner 12 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539282 | lotilaner 12 MG [Credelio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539283 | Credelio 12 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539283 | Credelio 12 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539283 | Credelio 12 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539285 | lotilaner 48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539286 | lotilaner 48 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539286 | lotilaner 48 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539287 | lotilaner 48 MG [Credelio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539288 | Credelio 48 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539288 | Credelio 48 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539288 | Credelio 48 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539289 | verdinexor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539290 | neomycin sulfate 0.00556 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539291 | neomycin sulfate 0.556 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539291 | neomycin sulfate 0.556 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539291 | neomycin sulfate 0.556 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539292 | Acorus calamus var. angustatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539293 | Agastache rugosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539294 | verdinexor 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539295 | verdinexor Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2539296 | verdinexor Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2539297 | verdinexor Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2539298 | verdinexor 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539298 | verdinexor 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539299 | Laverdia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2539300 | verdinexor 10 MG [Laverdia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539301 | verdinexor Oral Tablet [Laverdia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2539302 | Laverdia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2539303 | Laverdia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2539304 | Laverdia-CA1 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539304 | Laverdia-CA1 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539304 | Laverdia-CA1 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539304 | Laverdia-CA1 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539305 | verdinexor 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539306 | verdinexor 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539306 | verdinexor 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539307 | verdinexor 2.5 MG [Laverdia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539308 | Laverdia-CA1 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539308 | Laverdia-CA1 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539308 | Laverdia-CA1 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539308 | Laverdia-CA1 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539309 | verdinexor 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539310 | verdinexor 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539310 | verdinexor 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539311 | verdinexor 50 MG [Laverdia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539312 | Laverdia-CA1 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539312 | Laverdia-CA1 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539312 | Laverdia-CA1 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539312 | Laverdia-CA1 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25394 | Fumitoxin | Designated preferred name (PT) | NO | |
| RxCUI: 25394 | Fumitoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2539430 | salicylic acid 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539430 | salicylic acid 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539430 | salicylic acid 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539430 | salicylic acid 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539431 | Phlebodium aureum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2539434 | petrolatum 40 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539434 | petrolatum 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539434 | petrolatum 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539791 | Chrysanthemum x morifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539792 | Aniba rosaeodora whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539793 | Cryptolepis sanguinolenta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539794 | Ovis aries skin preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539795 | Rudbeckia hirta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539798 | bacitracin zinc 0.00048 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539799 | neomycin sulfate 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539800 | polymyxin B sulfate 0.006 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2539801 | bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539801 | bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539801 | bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539930 | Acer nigrum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539931 | Biancaea decapetala root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539932 | ferric maltol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2539933 | Hylotelephium telephium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539934 | Iris missouriensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539935 | Paeonia californica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539936 | Rosa luciae flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539937 | Umbellularia californica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539938 | azurite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2539939 | ferric maltol 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2539940 | ferric maltol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539941 | ferric maltol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539942 | ferric maltol Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2539943 | ferric maltol (iron 30 MG) 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539943 | ferric maltol (iron 30 MG) 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539943 | ferric maltol (iron 30 MG) 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539944 | Accrufer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2539945 | ferric maltol 30 MG [Accrufer] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2539946 | ferric maltol Oral Capsule [Accrufer] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2539947 | Accrufer Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2539948 | Accrufer Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2539949 | ACCRUFER 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539949 | ACCRUFER 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539949 | ACCRUFER 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539953 | Imectro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2539954 | ivermectin 0.034 MG / praziquantel 28.5 MG / pyrantel pamoate 28.5 MG [Imectro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539955 | ivermectin / praziquantel / pyrantel Chewable Tablet [Imectro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2539956 | Imectro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2539957 | Imectro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2539958 | Imectro Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2539959 | IMECTRO 34 uG / 28.5 MG / 28.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539959 | IMECTRO 34 uG / 28.5 MG / 28.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539959 | IMECTRO 34 uG / 28.5 MG / 28.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539960 | ivermectin 0.068 MG / praziquantel 57 MG / pyrantel pamoate 57 MG [Imectro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2539961 | IMECTRO 68 uG / 57 MG / 57 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539961 | IMECTRO 68 uG / 57 MG / 57 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539961 | IMECTRO 68 uG / 57 MG / 57 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539964 | pramoxine Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2539965 | pramoxine hydrochloride 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2539965 | pramoxine hydrochloride 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539965 | pramoxine hydrochloride 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2539965 | pramoxine hydrochloride 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539966 | ferric citrate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2539967 | dostarlimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2539967 | dostarlimab | Designated preferred name (PT) | YES | |
| RxCUI: 2539967 | dostarlimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2539967 | dostarlimab | Designated preferred name (PT) | YES | |
| RxCUI: 2539967 | dostarlimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2539968 | dostarlimab-gxly | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2539969 | dostarlimab-gxly 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2539970 | dostarlimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2539970 | dostarlimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2539970 | dostarlimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2539971 | dostarlimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2539972 | dostarlimab-gxly 500 MG in 10 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2539972 | dostarlimab-gxly 500 MG in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539972 | dostarlimab-gxly 500 MG in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539973 | Jemperli | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2539974 | dostarlimab-gxly 50 MG/ML [Jemperli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2539975 | dostarlimab Injection [Jemperli] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2539976 | Jemperli Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2539977 | Jemperli 500 MG in 10 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2539977 | Jemperli 500 MG in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539977 | Jemperli 500 MG in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2539977 | Jemperli 500 MG in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2539978 | dostarlimab-gxly 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2539979 | dostarlimab-gxly 50 MG/ML Injection [Jemperli] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2539979 | dostarlimab-gxly 50 MG/ML Injection [Jemperli] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |